PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,913,203 | +80.1% | 9,775,849 | 0.0% | 1.93% | +81.8% |
| Q2 2023 | $1,617,903 | -76.5% | 9,775,849 | +38.3% | 1.06% | -81.6% |
| Q1 2023 | $6,898,093 | +17.8% | 7,067,718 | +25.6% | 5.75% | +13.6% |
| Q4 2022 | $5,853,728 | +44.8% | 5,628,585 | +60.1% | 5.06% | +38.8% |
| Q3 2022 | $4,042,000 | -32.9% | 3,515,140 | +9.1% | 3.65% | -29.0% |
| Q2 2022 | $6,028,000 | +75.1% | 3,223,334 | +183.7% | 5.14% | +60.6% |
| Q1 2022 | $3,443,000 | +137.6% | 1,136,319 | +196.5% | 3.20% | +152.9% |
| Q4 2021 | $1,449,000 | – | 383,266 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |